Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q3

2796.TEDINET S100QKFA
Period2022-06-01 → 2023-02-28
Filed2023-04-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥38.7bn2022-06-01 → 2023-02-28Cons.Net sales
Revenue¥51.6bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥38.6bn2021-06-01 → 2022-02-28Cons.Net sales
Operating income¥896m2022-06-01 → 2023-02-28Cons.Operating income
Operating income¥1.0bn2021-06-01 → 2022-02-28Cons.Operating income
Ordinary income¥890m2022-06-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.5bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2021-06-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥722m2022-06-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥967m2021-06-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥208m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥447m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥322m2021-06-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income¥218m2022-06-01 → 2023-02-28Cons.Profit loss
Net income¥326m2021-06-01 → 2022-02-28Cons.Profit loss
Total assets¥22.9bnat 2023-02-28Cons.Assets
Total assets¥23.7bnat 2022-05-31Cons.Assets
Total assets¥23.8bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥16.1bnat 2023-02-28Cons.Liabilities
Total liabilities¥17.0bnat 2022-05-31Cons.Liabilities
Net assets / equity¥6.8bnat 2023-02-28Cons.Net assets
Net assets / equity¥6.7bnat 2022-05-31Cons.Net assets
Net assets / equity¥6.6bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥4.4bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥22.242022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.452022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.992021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥34.62021-06-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.682021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.892022-06-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥36.292021-06-01 → 2022-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.162021-06-01 → 2022-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio28.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio26.9%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio26.4%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥37m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥226m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2023-02-28−¥170m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2023-02-28¥56m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.1bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥70m
—segment totalrevenue2022-06-01 → 2023-02-28¥38.2bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥38.2bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-06-01 → 2022-02-28¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-06-01 → 2022-02-28¥560m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-06-01 → 2022-02-28¥22m
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-02-28−¥235m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2021-06-01 → 2022-02-28¥5.7bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2021-06-01 → 2022-02-28¥5.7bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2021-06-01 → 2022-02-28−¥151m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2021-06-01 → 2022-02-28¥516m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2021-06-01 → 2022-02-28¥516m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2021-06-01 → 2022-02-28¥71m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2021-06-01 → 2022-02-28¥31.4bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2021-06-01 → 2022-02-28¥31.4bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2021-06-01 → 2022-02-28¥1.2bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2021-06-01 → 2022-02-28¥377m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2021-06-01 → 2022-02-28¥377m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2021-06-01 → 2022-02-28¥48m
—segment totalrevenue2021-06-01 → 2022-02-28¥38.0bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥38.0bn
—segment totalsegment profit2021-06-01 → 2022-02-28¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-06-01 → 2022-02-28¥38.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-06-01 → 2022-02-28¥38.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-06-01 → 2022-02-28¥1.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 387
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member321100
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.033
Number of shares held in own name treasury shares etcCurrentQuarterInstant321100
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant321100
Shareholding ratio treasury shares etcCurrentQuarterInstant0.033
Cash and depositsPrior1YearInstant3991000000JPY
Cash and depositsCurrentQuarterInstant4421000000JPY
Accounts receivable tradePrior1YearInstant484000000JPY
Accounts receivable tradeCurrentQuarterInstant560000000JPY
Merchandise and finished goodsPrior1YearInstant2237000000JPY
Merchandise and finished goodsCurrentQuarterInstant3049000000JPY
Raw materials and suppliesPrior1YearInstant65000000JPY
Raw materials and suppliesCurrentQuarterInstant71000000JPY
Accounts receivable otherPrior1YearInstant3786000000JPY
Accounts receivable otherCurrentQuarterInstant2169000000JPY
Other caPrior1YearInstant319000000JPY
Other caCurrentQuarterInstant331000000JPY
Allowance for doubtful accounts caPrior1YearInstant-5000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-5000000JPY
Current assetsPrior1YearInstant10878000000JPY
Current assetsCurrentQuarterInstant10599000000JPY
Buildings and structures netPrior1YearInstant3121000000JPY
Buildings and structures netCurrentQuarterInstant2946000000JPY
LandPrior1YearInstant2616000000JPY
LandCurrentQuarterInstant2600000000JPY
Other net ppePrior1YearInstant617000000JPY
Other net ppeCurrentQuarterInstant565000000JPY
Property plant and equipmentPrior1YearInstant6355000000JPY
Property plant and equipmentCurrentQuarterInstant6112000000JPY
GoodwillPrior1YearInstant3220000000JPY
GoodwillCurrentQuarterInstant2939000000JPY
Other iaPrior1YearInstant409000000JPY
Other iaCurrentQuarterInstant405000000JPY
Intangible assetsPrior1YearInstant3629000000JPY
Intangible assetsCurrentQuarterInstant3344000000JPY
Other ioaPrior1YearInstant3045000000JPY
Other ioaCurrentQuarterInstant3032000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-164000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-153000000JPY
Investments and other assetsPrior1YearInstant2881000000JPY
Investments and other assetsCurrentQuarterInstant2878000000JPY
Noncurrent assetsPrior1YearInstant12866000000JPY
Noncurrent assetsCurrentQuarterInstant12335000000JPY
Deferred assetsPrior1YearInstant1000000JPY
Deferred assetsCurrentQuarterInstant0JPY
AssetsPrior1YearInstant23746000000JPY
AssetsCurrentQuarterInstant22935000000JPY
Accounts payable tradePrior1YearInstant4109000000JPY
Accounts payable tradeCurrentQuarterInstant4427000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2023-02-28pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-06-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass